ロード中...
Cisplatin induces HepG2 cell cycle arrest through targeting specific long noncoding RNAs and the p53 signaling pathway
Cisplatin has been used effectively in the treatment of hepatocellular carcinoma (HCC). Long noncoding RNAs (lncRNAs) were recently reported to contribute to the pathogenesis and progression of HCC. Their molecular mechanism related to cisplatin treatment remains unclear. The purpose of this study i...
保存先:
| 出版年: | Oncol Lett |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5228559/ https://ncbi.nlm.nih.gov/pubmed/28105167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.5288 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|